To search for clinically relevant circulating tumor cell (CTC) epitopes, we first co-stained the CD45-negative (CD45−) fraction of CRC blood samples from 13 patients with our potential CTC marker, CD44v6, and the known CTC marker EpCAM. This evidence concerns the gene EPCAM and neoplasm.